Jun 09, 2023 / 01:00PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
All right. We'll get started. Good morning, everybody. Thanks for joining us. Welcome to the Jefferies 2023 Global Healthcare Conference. I'm Brandon Couillard, I cover the tool space, here at the firm, very happy to have Bruker with us at the conference this morning. And here to give us an update on the CALID business, specifically, the President of that division, Juergen Srega, as well as Justin Ward, who heads up IR.
Turn it over to you, Juergen.
Juergen Srega - Bruker Corporation - President of Bruker CALID Group & Bruker Daltonics Division
Wonderful. Thanks, Brandon, for inviting us and opening the call. Good morning to all of you. My voice may be a little bit instable. I'm just coming from Houston with very cold hotel stay and heat outside. So it was a little bit of a challenge for my voice, I admit. But let's go quickly through updating you where are we at CALID. So I will have a focus on the group I am heading here and we'll give you some perspectives how we are doing and
Bruker Corp at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot